Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance

Area of Science:

• Oncology
• Cell Death Mechanisms

Background:

• Chemotherapeutic resistance is a major obstacle in cancer treatment.
• Cancer stem cells (CSCs) contribute to treatment resistance, recurrence, and poor clinical outcomes.
• CSCs are typically resistant to apoptosis-induced cell death.

Purpose of the Study:

• To explore the role of ferroptosis in eliminating CSCs.
• To review regulatory pathways controlling ferroptosis in CSCs.
• To discuss chemotherapeutic agents that induce ferroptosis in CSCs for improved outcomes.

Main Methods:

• Literature review of ferroptosis and CSCs.
• Analysis of regulatory pathways governing ferroptosis.
• Discussion of chemotherapeutic agents targeting CSCs via ferroptosis.

Main Results:

• Ferroptosis, a non-apoptotic cell death, can selectively eradicate CSCs.
• Understanding ferroptosis pathways provides insights into targeting aggressive CSCs.
• Certain chemotherapeutic agents show promise by inducing ferroptosis in CSCs.

Conclusions:

• Targeting ferroptosis is a promising strategy to overcome CSC-mediated chemoresistance.
• Induction of ferroptosis in CSCs may lead to improved cancer therapeutic outcomes.
• Further research into ferroptosis-inducing agents could enhance clinical efficacy.